◆ 会议时间：2025年7月2-5日
◆ 会议地点：西班牙 巴塞罗那

◆ 会议简介：

2025年欧洲肿瘤内科学会(ESMO)胃肠道癌症大会将于2025年7月2-5日在西班牙巴塞罗那举行，会议由欧洲肿瘤内科学会(ESMO)主办，ESMO胃肠道肿瘤大会将成为展示胃肠道肿瘤学领域有影响力的新数据的平台，科学会议将辅以高质量的教育会议和良好的交流机会。

欧洲肿瘤内科学会（ESMO）成立于1975年，是欧洲领先的肿瘤内科学专业组织，现在全球150多个国家和地区拥有超过23,000名会员，是肿瘤学教育和信息的参考学会，ESMO致力于支持其会员在快速发展的专业环境中得到发展与进步。作为一个非营利组织，ESMO一直以宣推动癌症护理和治疗为使命，致力于推进肿瘤医学专业的发展，以多学科的方法来促进癌症的治疗和护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

ESMO Gastrointestinal Cancers Congress 2025

Date: 2 - 5 July
Venue: Barcelona, Spain

Organized by:
European Society for Medical Oncology (ESMO)

The ESMO Gastrointestinal Cancers Congress 2025 will take place from 2 to 5 July in Barcelona, Spain, as well as online, through a dedicated virtual platform.

This important event will bring together leading experts, researchers, and healthcare professionals dedicated to the advancement of gastrointestinal cancers treatment and care.

Through groundbreaking presentations, multidisciplinary tumour boards, controversy sessions, and more, attendees will have the opportunity to delve into the latest research findings, innovative therapeutic strategies, and emerging technologies that are shaping the future of GI cancers treatment.

The programme will cover a wide spectrum of topics, including molecular prevention, diagnosis, precision therapy, and patient-centered care approaches in the treatment of GI malignancies.

Networking opportunities will abound, fostering connections among peers and facilitating the exchange of ideas and best practices.

Join us at the ESMO Gastrointestinal Cancers Congress 2025 to contribute to the global effort in improving outcomes for patients with GI cancers and to stay at the forefront of oncological advancements.

以下为上届会议信息

ESMO GI 2024 will take place as an onsite event in Munich, Germany, from 26 to 29 June 2024, as well as online, through a dedicated virtual platform. 

Brought to you by the European Society for Medical Oncology (ESMO), the congress will be the place to present impactful new data in GI oncology. The scientific sessions will be complemented with high quality educational sessions and excellent networking opportunities.

In recent years we have seen remarkable progress in the treatment options available for patients with GI cancers and ESMO is committed to ensuring that there is a clear roadmap to help facilitate the implementation of new practice changing discoveries in the clinic for the benefit of all patients with GI cancers and whose wellbeing is our primary concern.

The ESMO Gastrointestinal Cancers Congress will provide global visibility for original clinical and translational research.

Mark your agenda and ensure your participation in ESMO GI 2024.

We look forward to welcoming you to Munich!

摘要征文投稿：

Abstract submission deadlines

点此提交摘要>>>Submit Abstract>>>

• ESMO Gastrointestinal Cancers 2024 Abstract Regulations

Abstract submission categories

• Colon cancer
• Rectal cancer
• Upper digestive – Biliary, ampullary and pancreatic cancer
• Upper digestive – Esophageal and gastric cancers
• Hepatocellular and non-biliary liver cancer
• Rare GI cancers (GEP-NETs, endocrine pancreatic, duodenal cancer, anal cancer, etc)
• Miscellaneous

Late-breaking abstracts

Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.

The final late-breaking abstract deadline of 6 June 2024 is under no circumstances to be considered as an extension of the general submission deadline.

Trial in progress abstracts (TiP)

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Gastrointestinal Cancers Congress 2024.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.

Outcome notifications

Outcome notifications are expected to be made available to first authors and submitters by end-April.
Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by 10 June 2024.

Information for presenters

Detailed instructions for the preparation of slide presentations and/or posters will be made available by end-April in the section “Information for Presenters”.

Presentation and publication of accepted abstracts

The ESMO Gastrointestinal Cancers 2024 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

• Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
• Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
• Poster – Display session for review, discussion and questions. The presenting authors must be available onsite for Q&A to represent their work.

All accepted abstracts will be published online only in the ESMO Gastrointestinal Cancers 2024 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.

Publication schedule for accepted abstracts

Details regarding the publication of accepted abstracts are available here.

ESMO Merit Travel Grants

A restricted number of Merit Travel Grants to the ESMO Gastrointestinal Cancers Congress 2024 are available, upon application, to first author (= presenter) who submit abstracts considered to be deserving of recognition. Candidates must be ESMO Members under the age of 40. Selection will be made by the ESMO Gastrointestinal Cancers 2024 Scientific Committee on a competitive basis from among the accepted abstracts.

注册费：

Registration fees and deadlines

Individual registration will remain open for the duration of the congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines.

ESMO membership must be active seven (7) days prior to the registration deadline for the reduced member registration fee to be applied. Please visit the membership pages to check eligibility criteria, benefits, and to complete the membership application.

* Applicable to ESMO members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.
** ESMO Members must be under 40 and in training to qualify for this fee

In-person participation includes:

• Participation in scientific and educational live sessions with the possibility to interact with the expert panel
• Onsite networking opportunity with Faculty and peers
• Entry to the Poster and e-Poster area*
• Interaction with industry partners in the trade exhibition
• Participation in the Industry Satellite Symposia
• Access to the Virtual Platform to follow sessions live and/or view content on-demand*
• Post-event resources
• Coffee breaks

Online participation includes*:

• Access to the Virtual Platform, with live streaming of all sessions
• Possibility to interact through the chat live discussion
• Access to e-Posters
• Entry to the Virtual Exhibition
• Participation in the Industry Satellite Symposia
• Post-event resources

* Virtual platform will be accessible throughout the congress only

Confirmation

Beginning of June 2024, registered delegates will receive per email the registration confirmations and instructions on how to access the ESMO Gastrointestinal Cancers Congress 2024.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。